IQVIA Holdings Inc. (IQV) stock
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3014% above fair value
$257.60−7.13 (-2.69%)
Close on Nov 17, 2026Market cap $42.45BP/E 31.3Yield –
Iqvia total assets
Total assets on the balance sheet at the end of each period.
Iqvia's total assets was $30.47B at Sep 30, 2026. For fiscal 2025 it was $29.94B, up 11.3% from the year before. Over ten years it grew 22.5% a year on average. The highest annual figure on record is $29.94B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.94B | +11.3% |
| FY2024 | Dec 31, 2024 | $26.90B | +0.8% |
| FY2023 | Dec 31, 2023 | $26.68B | +5.3% |
| FY2022 | Dec 31, 2022 | $25.34B | +2.6% |
| FY2021 | Dec 31, 2021 | $24.69B | +0.5% |
| FY2020 | Dec 31, 2020 | $24.56B | +5.6% |
| FY2019 | Dec 31, 2019 | $23.25B | +3.1% |
| FY2018 | Dec 31, 2018 | $22.55B | -1.3% |
| FY2017 | Dec 31, 2017 | $22.86B | +7.8% |
| FY2016 | Dec 31, 2016 | $21.21B | +440.2% |
| FY2015 | Dec 31, 2015 | $3.93B | +19.1% |
| FY2014 | Dec 31, 2014 | $3.30B | +7.9% |
| FY2013 | Dec 31, 2013 | $3.05B | +22.2% |
| FY2012 | Dec 31, 2012 | $2.50B | +7.6% |
| FY2011 | Dec 31, 2011 | $2.32B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $30.47B | +6.1% |
| Q2 FY2026 | Jun 30, 2026 | $29.88B | +4.4% |
| Q1 FY2026 | Mar 31, 2026 | $29.68B | +8.6% |
| Q4 FY2025 | Dec 31, 2025 | $29.94B | +11.3% |
| Q3 FY2025 | Sep 30, 2025 | $28.73B | +5.7% |
| Q2 FY2025 | Jun 30, 2025 | $28.63B | +8.5% |
| Q1 FY2025 | Mar 31, 2025 | $27.32B | +2.8% |
| Q4 FY2024 | Dec 31, 2024 | $26.90B | +0.8% |
| Q3 FY2024 | Sep 30, 2024 | $27.18B | +4.6% |
| Q2 FY2024 | Jun 30, 2024 | $26.40B | +1.4% |
| Q1 FY2024 | Mar 31, 2024 | $26.57B | +3.2% |
| Q4 FY2023 | Dec 31, 2023 | $26.68B | +5.3% |
| Q3 FY2023 | Sep 30, 2023 | $25.98B | +7.2% |
| Q2 FY2023 | Jun 30, 2023 | $26.04B | +6.6% |
| Q1 FY2023 | Mar 31, 2023 | $25.74B | +3.1% |
| Q4 FY2022 | Dec 31, 2022 | $25.34B | +2.6% |
| Q3 FY2022 | Sep 30, 2022 | $24.22B | +0.8% |
| Q2 FY2022 | Jun 30, 2022 | $24.41B | +2.0% |
| Q1 FY2022 | Mar 31, 2022 | $24.97B | +2.1% |
| Q4 FY2021 | Dec 31, 2021 | $24.69B | +0.5% |
| Q3 FY2021 | Sep 30, 2021 | $24.03B | +0.8% |
| Q2 FY2021 | Jun 30, 2021 | $23.94B | +3.3% |
| Q1 FY2021 | Mar 31, 2021 | $24.47B | +6.0% |
| Q4 FY2020 | Dec 31, 2020 | $24.56B | +5.6% |
| Q3 FY2020 | Sep 30, 2020 | $23.84B | +4.1% |
| Q2 FY2020 | Jun 30, 2020 | $23.18B | +0.5% |
| Q1 FY2020 | Mar 31, 2020 | $23.08B | -0.1% |
| Q4 FY2019 | Dec 31, 2019 | $23.25B | +3.1% |
| Q3 FY2019 | Sep 30, 2019 | $22.89B | +1.8% |
| Q2 FY2019 | Jun 30, 2019 | $23.07B | +2.0% |
| Q1 FY2019 | Mar 31, 2019 | $23.11B | -0.5% |
| Q4 FY2018 | Dec 31, 2018 | $22.55B | -1.3% |
| Q3 FY2018 | Sep 30, 2018 | $22.50B | +0.2% |
| Q2 FY2018 | Jun 30, 2018 | $22.63B | +3.9% |
| Q1 FY2018 | Mar 31, 2018 | $23.24B | +9.7% |
| Q4 FY2017 | Dec 31, 2017 | $22.86B | +7.8% |
| Q3 FY2017 | Sep 30, 2017 | $22.45B | – |
| Q2 FY2017 | Jun 30, 2017 | $21.78B | – |
| Q1 FY2017 | Mar 31, 2017 | $21.18B | – |
| Q4 FY2016 | Dec 31, 2016 | $21.21B | – |
See a number that looks wrong?